Krystyn Elizabeth

Non-officer stockholder Krystyn Elizabeth liquidated full position across two days, disposing of over 404k shares for $4.3M as stock trades well below highs.

Krystyn Elizabeth, who holds no officer or director role, executed a complete exit from Baldwin Insurance on May 6–7, selling 404,000 shares across four transactions totaling approximately $4.3 million while the stock trades significantly below its 52-week high. The sale came amid company fundamentals that remain pressured—Baldwin posted an annual net loss and currently trades near the lower end of its 52-week range—suggesting the shareholder was responsive to weakness rather than long-term conviction. Prior sales by Elizabeth at this company show mixed timing: her two most recent exits in March saw the stock subsequently rise modestly, indicating poor timing, but her three earlier exits in late 2024 all preceded declines, marking well-timed exits over a longer horizon. The liquidation reverses a brief return to accumulation (200,000 shares acquired via conversion in early May) before Elizabeth fully exited, a pattern that hints at portfolio consolidation rather than strategic repositioning in this particular holding.

Krystyn Elizabeth sold 119,987 shares at $21.25 on 2026-03-06 for $2,549,723.75 (derivative conversion), now 0 post-transaction

Krystyn Elizabeth executed 2 separate sales totaling 119,987 shares at $21.25 on 2026-03-06 for $2,549,723.75. This filing involves a conversion of derivative securities; the insider's derivative holdings in Form 4 Table II are not yet populated in our database, so the 0 post-transaction shares reflects only Table I and does not represent the full position. Notably, her prior 5 trades at BWIN were all well-timed at the 90-day mark, with each sale followed by declines ranging from -6.0% to -15.2% over 90 days; her cross-ticker track record shows a 90-day well-timed rate of 100.00%. The company is currently unprofitable (full-year net income was negative) and trading -54.7% from its 52-week high of $46.41, having declined -16.0% over the past 90 days. The insider's sales at $21.25 now sit above the current price of $21.03, reflecting a slight near-term margin. The timing and pattern of this transaction merit close attention given the insider's demonstrated historical accuracy on this name.

Insider Krystyn Elizabeth sold 423,877 shares over 3 days (Dec 9–11) for $18.8M at blended avg $44.26; stock now $42.86, down 12.4% in 30 days.

Krystyn Elizabeth executed 6 separate sales over three consecutive trading days (Dec 9–11, 2024), totaling 423,877 shares for $18,761,667.95 at a blended average price of $44.26. The transaction occurred while the stock traded between $43.05 and $46.75, with execution prices distributed across that range. Post-transaction, the insider holds derivative securities per Form 4 Table II (not yet populated in this database entry), so this represents a disposition of a specific tranche rather than a complete position exit. The company's fundamentals show annual revenue growth of +24.2%, but the most recent full fiscal year generated net income of $-8,377,000.00 (negative), and the latest quarter revenue was $338.9M against net income of $-8.4M. Since the trade, the stock has declined to $42.86 (-22.5% from its 52-week high of $55.29 and -12.4% over the past 30 days), putting the execution prices above the current market level.